A shared name is not a shared structure
DAC refers to a drug-affinity-complex modification in the long-acting research material. No DAC or without DAC identifies a different presentation in this catalogue. Mod GRF 1-29 is a common search name used for the latter.
Informal supplier terminology can be inconsistent. Confirm exact sequence, modification and the material identified in the batch documents rather than choosing by the CJC-1295 name alone.
Do not transfer the long-acting trial timeline
The Teichman study reports pharmacokinetic and endocrine observations for the long-acting CJC-1295 material studied there. Its results do not establish the duration of a No DAC vial.
When citing the paper, retain the tested material and study population. Avoid copying half-life or response-duration figures onto a different material or a blend page without direct evidence.
Single compound or Ipamorelin blend?
A No DAC single-material vial is distinct from the CJC-1295 No DAC + Ipamorelin blend. The blend needs two constituent identities and two amount records, not just one total mass.
Read the linked blend comparison when deciding which presentation meets a laboratory procurement specification. None of these pages provide administration schedules or instructions for personal use.
Document the procurement decision
Record why a particular form is needed, its labelled quantity, exact batch identity and available analytical methods. Match the current product page to the quotation and invoice.
If the label, certificate and protocol use inconsistent names, resolve the discrepancy before accepting the material. A low price does not resolve an identity mismatch.